Short-term COVID-19 vaccine adverse effects among adults in Ekiti State, Nigeria-Reference-Cited by-同舟云学术

Short-term COVID-19 vaccine adverse effects among adults in Ekiti State, Nigeria

Published:2024-02-22 Issue:4 Volume:40 Page:621-627
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Dele-Ojo Bolade Folasade¹²^ORCID,Adesokan Adedapo³,Fadare Joseph Olusesan⁴^ORCID,Ajayi Paul Oladapo⁵,Raimi Taiwo Hussean¹²,Dada Samuel Ayokunle¹²,Ojo Owolabi Dele⁶,Ogunmodede James Ayodele⁷,Ipinnimo Tope Michael⁸,Ariyo Olumuyiwa Elijah⁹,Godman Brian¹⁰¹¹^ORCID

Affiliation:

1. Department of Medicine, Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria

2. Department of Medicine, Ekiti State University, Ado-Ekiti, Nigeria

3. Emergency Medicine Department, Kingsmill Hospital, Sutton-in-Ashfield, Scotland

4. Department of Pharmacology and Therapeutics, Ekiti State University, Ado-Ekiti, Nigeria

5. Department of Community Medicine, Ekiti State University, Ado-Ekiti, Nigeria

6. Department of Surgery, Afe Babalola University, Ado-Ekiti, Nigeria

7. Department of Medicine, University of Ilorin, Ilorin, Nigeria

8. Department of Community Medicine, Federal Teaching Hospital, Ido-Ekiti, Nigeria

9. Department of Medicine, Faculty of Clinical Sciences, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, Nigeria

10. Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa

11. Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, United Kingdom

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2316217

Reference65 articles.

1. World Health Organisation. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int.

2. The lightning-fast quest for COVID vaccines — and what it means for other diseases

3. Lessons learned from COVID-19 pandemic: Vaccine platform is a key player

4. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

5. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial